Discovery of cytokine mimics using cell-based systems

Drug Discovery Today

Volumn 5, Issue 12 SUPPL. 1, 2000, Pages

  Miller, Stephen G ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; DRUG; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROTEIN; RECEPTOR STIMULATING AGENT; RECOMBINANT CYTOKINE; UNCLASSIFIED DRUG;

BIOCHEMISTRY; CELL ASSAY; DIMERIZATION; DRUG IDENTIFICATION; FUNCTION TEST; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; MELANOPHORE; MOLECULAR CLONING; MOLECULAR MIMICRY; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; REPORTER GENE; REVIEW; SCREENING;

EID: 10644278955     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)80078-1     Document Type: Review

References (63)

1. Treatment of multiple sclerosis with interferon beta
2. Hematopoietic growth factors in cancer chemotherapy
3. Antibodies to interferon in patients undergoing IFN therapy: An update
4. Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia
5. Cutaneous reactions to recombinant cytokine therapy
6. Interferon β-1b injection site reactions and necroses
7. Pharmacokinetic considerations of new insulin formulations and routes of administration
8. Genetically engineered insulin analogs: Diabetes in the new millennium
9. Nonpeptidic ligands for peptide and protein receptors
10. Small peptides as potent mimetics of the protein hormone erythropoietin
11. Isolation of erythropoietin receptor agonist peptides using evolved phage libraries
12. Activation of the erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site
13. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine
14. Discovery of a novel thrombopoietin mimic agonist peptide
15. A designed peptidomimetic agonist ligand of TrkA nerve growth factor receptors
16. Oral controlled release technology for peptides: Status and future prospects
17. Bioavailability and transport of peptides and peptide drugs into the brain
18. Minimized proteins
19. A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor
20. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl
21. Mimicry of erythropoietin by a nonpeptide molecule
22. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice
23. Dimerization of cell surface receptors in signal transduction
24. Erythropoietin receptor activation by a ligand-induced conformation change
25. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
26. The structure, organization, activation and plasticity of the erythropoietin receptor
27. New epoetin molecules and novel therapeutic approaches
28. Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 Å
29. Reporter gene technology: The future looks bright
30. Drug discovery using receptors that modulate gene expression
31. q-coupled receptors by a multiple response element/cAMP response element-directed reporter assay
32. A reporter gene assay for high-throughput screening of G-protein-coupled receptors stably or transiently expressed in HEK293 EBNA cells grown in suspension culture
33. Cytokines and STAT signaling
34. A cellular reporter assay to monitor insulin receptor kinase activity based on STAT5-dependent luciferase gene expression
35. A sensitive and versatile bioassay for ligands that signal through receptor clustering
36. Miniaturization of a mammalian cell-based assay: Luciferase reporter gene readout in a 3 microliter 1536-well plate
37. High-throughput screening for ligand-induced c-fos mRNA expression by branched DNA assay in Chinese hamster ovary cells
38. A genome-wide functional assay of signal transduction in living mammalian cells
39. Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput kinase receptor activation enzyme-linked immunosorbant assay
40. Kinase receptor activation (KIRA): A rapid and accurate alternative to end-point bioassays
41. Ratiometric assay of epidermal growth factor receptor tyrosine kinase activation
42. Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay
43. Quantitative, high-throughput cell-based assays for inhibitors of trkA receptor
44. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule
45. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex
46. Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors
47. Homodimerization and constitutive activation of the erythropoietin receptor
48. Rational design of potent antagonists to the human growth hormone receptor
49. JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization
50. Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays
51. Epidermal growth factor receptor dimerization monitored in live cells
52. Fluorescence resonance energy transfer reveals interleukin (IL)-1-dependent aggregation of IL-1 Type I receptors that correlates with receptor activation
53. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation
54. PRIM: Proximity imaging of green fluorescent protein-tagged polypeptides
55. A high-throughput assay to identify compounds that can induce dimerization of the erythropoietin receptor
56. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation
57. Efficiency of signalling through cytokine receptors depends critically on receptor orientation
58. Single-molecule imaging of EGFR signalling on the surface of living cells
59. s protein coupled receptors using a recombinant melanophore-based bioassay
60. A rapid bioassay for platelet-derived growth factor β-receptor function
61. A melanophore-based screening assay for erythropoietin receptors
62. High throughput quantitation of cAMP production mediated by activation of seven transmembrane domain receptors
63. 2+] using the Fluorometric Imaging Plate Reader (FLIPR)